Correlation Between Blueprint Medicines and Ardelyx

Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Blueprint Medicines Corp and Ardelyx, you can compare the effects of market volatilities on Blueprint Medicines and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Ardelyx.

Diversification Opportunities for Blueprint Medicines and Ardelyx

0.27

Correlation Coefficient

Blueprint Medicines  Ardelyx

Modest diversification

The 3 months correlation between Blueprint and Ardelyx is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Ardelyx go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Ardelyx

Given the investment horizon of 90 days Blueprint Medicines Corp is expected to under-perform the Ardelyx. But the stock apears to be less risky and, when comparing its historical volatility, Blueprint Medicines Corp is 1.36 times less risky than Ardelyx. The stock trades about -0.02 of its potential returns per unit of risk. The Ardelyx is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  558.00  in Ardelyx on December 4, 2024 and sell it today you would lose (50.00) from holding Ardelyx or give up 8.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Blueprint Medicines Corp  vs.  Ardelyx

Blueprint Medicines Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Blueprint Medicines Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Blueprint Medicines is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Ardelyx

Risk-Adjusted Performance

Weak

Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Ardelyx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Blueprint Medicines and Ardelyx

The main advantage of trading using opposite Blueprint Medicines and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.

The idea behind Blueprint Medicines Corp and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.